NasdaqCM - Nasdaq Real Time Price USD

Ekso Bionics Holdings, Inc. (EKSO)

Compare
1.0400 +0.0200 (+1.96%)
At close: October 25 at 4:00 PM EDT
1.0599 +0.02 (+1.91%)
After hours: October 25 at 7:49 PM EDT
Loading Chart for EKSO
DELL
  • Previous Close 1.0200
  • Open 1.0000
  • Bid --
  • Ask --
  • Day's Range 1.0000 - 1.0600
  • 52 Week Range 0.8270 - 3.1290
  • Volume 56,560
  • Avg. Volume 86,743
  • Market Cap (intraday) 22.406M
  • Beta (5Y Monthly) 1.46
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7900
  • Earnings Date Oct 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.25

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

www.eksobionics.com

70

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EKSO

View More

Performance Overview: EKSO

Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EKSO
58.40%
S&P 500
21.77%

1-Year Return

EKSO
25.30%
S&P 500
36.74%

3-Year Return

EKSO
73.33%
S&P 500
27.79%

5-Year Return

EKSO
88.35%
S&P 500
92.94%

Compare To: EKSO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EKSO

View More

Valuation Measures

Annual
As of 10/25/2024
  • Market Cap

    22.41M

  • Enterprise Value

    23.21M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.92

  • Price/Book (mrq)

    1.86

  • Enterprise Value/Revenue

    1.28

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -68.41%

  • Return on Assets (ttm)

    -24.54%

  • Return on Equity (ttm)

    -83.20%

  • Revenue (ttm)

    18.16M

  • Net Income Avi to Common (ttm)

    -12.42M

  • Diluted EPS (ttm)

    -0.7900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.88M

  • Total Debt/Equity (mrq)

    55.49%

  • Levered Free Cash Flow (ttm)

    -6.36M

Research Analysis: EKSO

View More

Company Insights: EKSO

Research Reports: EKSO

View More

People Also Watch